Scientists Demonstrate Utility of Bilateral Tumor Model for Evaluating Anti-Cancer T-cell Responses
Similar Posts
RevSpring Launches Engage IQ™, a Patient Engagement Platform that Delivers One Coordinated Experience for Clinical, Administrative and Financial Interactions
Engage IQ centers on patient understanding to deliver a wholistic experience that is effortless and personal, which optimizes…
New CurrentMD COVID App Facilitates Just-in-Time Learning for Frontline Physicians
Launched by Knowledge to Practice, the new app delivers emerging COVID-19 information directly to providers’ mobile devices Physicians now…
Harvard Researchers Find Significant Clinical Impact and Savings with MedAware’s Patient Safety Platform
Study published by The Joint Commission Journal of Quality and Patient Safety finds ~70% of MedAware’s AI-enabled clinical interventions…
